Hoth Therapeutics, Inc. is named one of the 15 Best Biotech Penny Stocks to Invest in Right Now, focusing on dermatology, oncology, and neurology. They offer innovative solutions like BioLexa for antimicrobials and HT-ALZ for neurodegenerative conditions, addressing unmet medical needs such as eczema and chronic wounds.

In September 2025, Hoth Therapeutics, Inc. announced advancements in its programs, including global expansion of HT-001, a therapy for skin toxicities. They also progressed with HT-KIT for rare mast cell cancers and launched a veteran obesity program, enhancing their pipeline through strategic collaborations.

Hoth Therapeutics, Inc. is expanding its treasury reserve to include up to $1 million in Bitcoin, Ethereum, and Solana, demonstrating a focus on asset diversification and innovative capital management. While HOTH shows potential as an investment, there are AI stocks with greater upside potential and less downside risk.

Read more at Yahoo Finance: Hoth Therapeutics, Inc. (HOTH) Files EMA Application for Global Expansion of HT-001 Skin Therapy